Turning Point Therapeutics


Turning Point Therapeutics is a public, clinical-stage precision oncology company with three molecules in clinical development and one in IND-enabling studies. 


View Website

Turning Point Therapeutics

Turning Point Therapeutics Key Stats

Life Sciences, Precision Health

Central